Positional cloning reveals strain-dependent expression of Trim16 to alter susceptibility to bleomycin-induced pulmonary fibrosis in mice.
Pulmonary fibrosis is a disease of significant morbidity, with no effective therapeutics and an as yet incompletely defined genetic basis. The chemotherapeutic agent bleomycin induces pulmonary fibrosis in susceptible C57BL/6J mice but not in mice of the C3H/HeJ strain, and this differential strain...
Guardado en:
Autores principales: | Anguel N Stefanov, Jessica Fox, François Depault, Christina K Haston |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60463f722b93447487450e9611e4c3f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of simvastatin on bleomycin-induced pulmonary fibrosis in female rats
por: Tulek,Baykal, et al.
Publicado: (2012) -
Protective and therapeutic effect of felodipine against bleomycin-induced pulmonary fibrosis in mice
por: Ken-ichiro Tanaka, et al.
Publicado: (2017) -
Water-Soluble C60 Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Dong R, et al.
Publicado: (2020) -
TRIM proteins in fibrosis
por: Hao Qian, et al.
Publicado: (2021) -
Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2
por: Xiang Tong, et al.
Publicado: (2021)